From: A Placebo-Controlled Trial of Riboflavin for Enhancement of Ultramarathon Recovery
Characteristic | Riboflavin (n = 18) | Placebo (n = 14) |
---|---|---|
Age (years) | 44 ± 8 | 46 ± 7 |
Sex (% men) | 83 | 79 |
Average weekly running distance (km)a | 83 ± 20 | 94 ± 20 |
Highest week running distance (km)a | 135 (126–156) | 129 (120–142) |
Longest training run or race (km)a | 80 (66–92) | 80 (56–97) |
Body mass change from registration to post-race (%) | −3.6 ± 2.1 | −2.6 ± 2.0 |
Finish time (hours) | 27.26 ± 2.36 | 27.08 ± 2.88 |
Used any pain medication during the race (%) | 50 | 36 |
Used any pain medication in 10 days post-race (%) | 33 | 43 |
Post-race plasma CK (U/L) | 6804 (3536–24,592) | 12,819 (7560–46,965) |